Management of the Rh-negative gravida.
D000017:ABO Blood-Group System / Q000032:analysis; D000359:Aftercare; D000650:Amnion / Q000000981:diagnostic imaging; D000653:Amniotic Fluid / Q000032:analysis*; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001789:Blood Group Antigens; D001805:Blood Transfusion, Intrauterine; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D005313:Fetal Death / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011677:Punctures / Q000009:adverse effects; D011859:Radiography; D012204:Rh-Hr Blood-Group System; D013053:Spectrophotometry; D005719:gamma-Globulins / Q000627:therapeutic use
D000017:ABO Blood-Group System; D000906:Antibodies; D001789:Blood Group Antigens; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins